A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host Disease
Clinical trial NCT01028313 · WITHDRAWN
Trial details
- NCT number
- NCT01028313
- Sponsor
- SCRI Development Innovations, LLC
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.